Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated with adjuvant gemcitabine-based chemotherapy.

k6654_3

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

k6654_3.pdf

https://hiroshima.repo.nii.ac.jp/record/2004896/files/k6654_3.pdf

ファイル	ライセンス
k6654_3.pdf (1.2 MB) sha256 73b4c31cc260a6f4b6c95256b369d4f74006261c8bf9a4f0153f58dcb051883e

Version	Date Modified	Object File Name	File Size	File Hash Value	Contributor Name	Show/Hide

Downloads

Plays